Approval · Notice of Compliance 32287 · 2023
COSOPT: Notice of Compliance 32287
Issued December 5, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32287
- Date
- December 5, 2023
- Company
- Elvium Life SciencesToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To update the Product Monograph (PM) with new safety information and additional instruction for administration
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| COSOPT | Not yet assigned | — |
| COSOPT PRESERVATIVE-FREE | Not yet assigned | — |
Medicinal ingredients
- TIMOLOL MALEATE 6.83 MG per ML
- DORZOLAMIDE HYDROCHLORIDE 22.26 MG per ML
- TIMOLOL MALEATE 22.26 MG per ML
- DORZOLAMIDE HYDROCHLORIDE 6.83 MG per ML